Next Article in Journal
Journal of Functional Biomaterials Best Paper Award 2015
Next Article in Special Issue
Human Keratoconus Cell Contractility is Mediated by Transforming Growth Factor-Beta Isoforms
Previous Article in Journal
Biomimetic Hybrid Nanofiber Sheets Composed of RGD Peptide-Decorated PLGA as Cell-Adhesive Substrates
Previous Article in Special Issue
Treatment of Silk Fibroin with Poly(ethylene glycol) for the Enhancement of Corneal Epithelial Cell Growth
Article Menu

Export Article

Open AccessReview
J. Funct. Biomater. 2015, 6(2), 379-394;

Lipid Nanoparticles for Ocular Gene Delivery

Dean A. McGee Eye Institute, Oklahoma City, OK 73104, USA
Department of Ophthalmology, College of Medicine, University of Oklahoma, Oklahoma City, OK 73014, USA
Department of Physiology and Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73014, USA
Author to whom correspondence should be addressed.
Academic Editor: Dimitrios Karamichos
Received: 1 May 2015 / Revised: 1 June 2015 / Accepted: 2 June 2015 / Published: 8 June 2015
(This article belongs to the Special Issue Ocular Tissue Engineering)
Full-Text   |   PDF [411 KB, uploaded 8 June 2015]   |  


Lipids contain hydrocarbons and are the building blocks of cells. Lipids can naturally form themselves into nano-films and nano-structures, micelles, reverse micelles, and liposomes. Micelles or reverse micelles are monolayer structures, whereas liposomes are bilayer structures. Liposomes have been recognized as carriers for drug delivery. Solid lipid nanoparticles and lipoplex (liposome-polycation-DNA complex), also called lipid nanoparticles, are currently used to deliver drugs and genes to ocular tissues. A solid lipid nanoparticle (SLN) is typically spherical, and possesses a solid lipid core matrix that can solubilize lipophilic molecules. The lipid nanoparticle, called the liposome protamine/DNA lipoplex (LPD), is electrostatically assembled from cationic liposomes and an anionic protamine-DNA complex. The LPD nanoparticles contain a highly condensed DNA core surrounded by lipid bilayers. SLNs are extensively used to deliver drugs to the cornea. LPD nanoparticles are used to target the retina. Age-related macular degeneration, retinitis pigmentosa, and diabetic retinopathy are the most common retinal diseases in humans. There have also been promising results achieved recently with LPD nanoparticles to deliver functional genes and micro RNA to treat retinal diseases. Here, we review recent advances in ocular drug and gene delivery employing lipid nanoparticles. View Full-Text
Keywords: gene therapy; non-viral vectors; lipid nanoparticles; solid lipid nanoparticles; liposomes gene therapy; non-viral vectors; lipid nanoparticles; solid lipid nanoparticles; liposomes

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Wang, Y.; Rajala, A.; Rajala, R.V.S. Lipid Nanoparticles for Ocular Gene Delivery. J. Funct. Biomater. 2015, 6, 379-394.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Funct. Biomater. EISSN 2079-4983 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top